Login / Signup

What are the current and projected future cost and health-related quality of life implications of scaling up cognitive stimulation therapy?

Martin KnappAnnette BauerRaphael WittenbergAdelina Comas-HerreraEva CyhlarovaBo HuCarol JaggerAndrew KingstonAnita PatelAimee SpectorAudrey WesselGloria Hoi-Yan Wong
Published in: International journal of geriatric psychiatry (2021)
Scaling-up CST England for people with incident dementia can improve lives in an affordable, cost-effective manner. Adding MCST also improves health-related quality of life, but the economic evidence is less compelling.
Keyphrases
  • mild cognitive impairment
  • cardiovascular disease
  • climate change
  • cognitive impairment
  • current status
  • stem cells
  • mesenchymal stem cells